Amanda(Herzog)ParkesMD
Oncology • Thousand Oaks, CAMedical Director Oncology Early Development, Amgen
Dr. Parkes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Amgen - Corporate Headquarters
1 Amgen Center Dr
Thousand Oaks, CA 91320
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
University of Wisconsin School of Medicine & Public HealthClass of 2012
Certifications & Licensure
WI State Medical License 2017 - 2025
TX State Medical License 2016 - 2020
MA State Medical License 2012 - 2015- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 126 citationsSoft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.Margaret von Mehren, John M Kane, Mark Agulnik, Marilyn M Bui, Janai Carr-Ascher
Journal of the National Comprehensive Cancer Network. 2022-07-01 - 43 citationsPrognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only MetastasesAmanda Parkes, Carla L. Warneke, Katherine Clifton, Aydah Al-Awadhi, Oluchi Oke
The Oncologist. 2018-11-01 - 34 citationsNCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.Margaret von Mehren, John M Kane, Richard F Riedel, Jason K Sicklick, Seth M Pollack
Journal of the National Comprehensive Cancer Network. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
